Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma

Xuehe Liu, Feiyan Xie, Jin Ding, Suhua Li, Jixi Li

Open source

DOI
10.3389/fonc.2023.1164214
Published
2023-03-30
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1164214,
  title = {Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma},
  author = {Xuehe Liu and Feiyan Xie and Jin Ding and Suhua Li and Jixi Li},
  year = {2023},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2023.1164214},
  url = {https://doi.org/10.3389/fonc.2023.1164214}
}

RIS

TY  - JOUR
TI  - Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
AU  - Xuehe Liu
AU  - Feiyan Xie
AU  - Jin Ding
AU  - Suhua Li
AU  - Jixi Li
PY  - 2023
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2023.1164214
UR  - https://doi.org/10.3389/fonc.2023.1164214
ER  - 

APA

Liu, X., Xie, F., Ding, J., Li, S., & Li, J. (2023). Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1164214

Source records